BRAF inhibitor cessation prior to disease progression in metastatic melanoma: Long-term outcomes
Year: 2022
Type: article
Study design: Observational Study
Source: European Journal of Cancer
Authors: Joanna Lee, Tasnia Ahmed, Andrea Maurichi, Lorenza Di Guardo, Anna M. Stagno, Lydia Warburton, Amelia. M. Taylor, Elisabeth Livingstone, Saba Rehman, Adnan Khattak, Katharina C. Kahler, Vito Vanella, Victoria Atkinson, Michael Millward, Dirk Schadendorf, Douglas B. Johnson, Paolo A. Ascierto, Axel Hauschild, Serigne N. Lo, Georgina V. Long, Alexander M. Menzies, Matteo S. Carlino
Institutions: Westmead Hospital, The University of Sydney, Melanoma Institute Australia, Fondazione IRCCS Istituto Nazionale dei Tumori, Azienda Ospedaliera San Gerardo, Fiona Stanley Hospital, Essen University Hospital, Deutsches Konsortium für Translationale Krebsforschung, Vanderbilt University, Vanderbilt University Medical Center, Edith Cowan University, University Hospital Schleswig-Holstein, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", The University of Queensland, Greenslopes Private Hospital, Princess Alexandra Hospital, The University of Western Australia, Royal North Shore Hospital
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4308926134